Submit Content
Sponsored in Part By
Sponsored

Two-Year Outcomes With a Magnetically Levitated Cardiac Pump in Heart Failure

Submitted by
Mar. 12, 2018
0

An interesting two-year report from the MOMENTUM 3 randomized controlled trial comparison of HeartMate 3 and II, the analysis performed by Abbott. Although stroke and reoperation were clearly lower with the latest technology, reflected in the lower LDH measurements, there was bafflingly no improvement in survival.

 

View Source Article
0 comments

Leave a Reply

Source

The New England Journal of Medicine

Authors

Mandeep R. Mehra, Daniel J. Goldstein, Nir Uriel, Joseph C. Cleveland, Melana Yuzefpolskaya, Christopher Salerno, Mary N. Walsh, Carmelo A. Milano, Chetan B. Patel, Gregory A. Ewald, Akinobu Itoh, David Dean, Arun Krishnamoorthy, William G. Cotts, Antone J. Tatooles, Ulrich P. Jorde, Brian A. Bruckner, Jerry D. Estep, Valluvan Jeevanandam, Gabriel Sayer, Douglas Horstmanshof, James W. Long, Sanjeev Gulati, Eric R. Skipper, John B. O’Connell, Gerald Heatley, Poornima Sood, and Yoshifumi Naka, for the MOMENTUM 3 Investigators

Tags

Heart Transplant Basic science Heart Failure - Nonischemic VAD Heart Failure - Ischemic Clinical Epidemiology Extracorporeal circulation Heart Failure - Congestive Mechanical Circulatory Assistance Cardiac - Other Transplantation - Heart Cardiac Heart Failure

Log In

New to CTSNet? Sign Up

Forgot Password